MAP4K4 inhibitors
US12247045B2 · kind B2 · utility
0Cited by
1References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 4, 2019 |
| Grant date | Mar 11, 2025 |
| Priority date | — |
| Expiry date | Dec 28, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use these compounds, for example in a method of treatment of cardiac conditions. In particular, the present invention relates to compounds of formula (I):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.